NCT04322240View on ClinicalTrials.gov

Alpha Lipoic Acid and Diabetes Mellitus: Potential Effects on Peripheral Neuropathy

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

April 2, 2020

Primary Completion Date

October 23, 2020

Study Completion Date

December 23, 2020

Conditions
Diabetic PolyneuropathyDiabetes Mellitus, Type 2
Interventions
DRUG

Alpha lipoic acid

Participants will be prescribed 600 mg/day ALA (thiotacid) orally, for 3 months, and will be advised not to discontinue this medication

Trial Locations (1)

13518

Benha University Hospital, Banhā

All Listed Sponsors
lead

Benha University

OTHER

NCT04322240 - Alpha Lipoic Acid and Diabetes Mellitus: Potential Effects on Peripheral Neuropathy | Biotech Hunter | Biotech Hunter